CongFeng Bio focuses on the application of cryo technology in the field of innovative minimally invasive interventional medical devices in the cardiovascular field. After nearly 4 years of research and exploration, the company has overcome the key technology of cryo ablation equipment and catheters, and has successfully developed the denervation sympathetic ablation system and the atrial fibrillation cryo ablation system, of which the denervation sympathetic ablation system has obtained the approval certificate of the national CFDA The system has been approved by the CFDA for green approval channel.
Concentric Bio has applied for more than 40 patents, some of which have entered the United States and Europe.
Legal representative: Li Kejian
Establishment: 2013-03-15
Registered capital: 21.39 million yuan
Industrial and Commercial Registration No.: 310115400284925
Enterprise type: Limited Liability Company (Sino-foreign equity joint venture)
Corporate address: No. 15, Lane 3399, Kangxin Highway, Pudong District, Shanghai, China. No.15, Lane 3399, Kangxin Highway?
Kang Feng Biotechnology (Shanghai) Co., Ltd. is a limited liability company (sino-foreign equity joint venture) registered on 2013-03-15 in Pudong New Area, Shanghai, with a registered address at No. 15, Lane 3399, Kangxin Highway, Pudong New Area, Shanghai.
The unified social credit code/registration number of Hongfeng Biotechnology (Shanghai) Co., Ltd. is 91310115062524037K, and the enterprise's legal person is Li Kejian, and the enterprise is currently in the state of opening.
The business scope of Hongfeng Biotechnology (Shanghai) Co., Ltd. is as follows: the design of biomaterials testing instruments, medical cold therapy equipment, interventional devices, and to provide related technical consulting services; medical devices (Class I), laboratory equipment, medical polymer materials and metal materials, pipe fittings, wholesale, commission agency (except auctions), and import and export and its related ancillary services
(not involving state trade management, involving quota, license management commodities, in accordance with relevant state regulations for application). Items subject to approval in accordance with the law, can only carry out business activities after approval by the relevant departments.
In Shanghai, the total registered capital of companies with similar business scope is 288,147,000 yuan, and the main capital is concentrated in 10-50 million and more than 50 million size of the enterprise, ****94. Within the province, the current registered capital of enterprises belongs to good.